Organ transplantation is undergoing profound changes. Contraindications for donation have
been revised in order to better meet the organ demand. The use of lower-quality organs and …

A decision to withdraw life-sustaining treatment (WLST) is derived by a conclusion that
further treatment will not enable a patient to survive or will not produce a functional outcome …

Primary graft dysfunction (PGD) is the clinical syndrome of acute lung injury after lung
transplantation (LTx). However, PGD is an umbrella term that encompasses the ongoing …

Pre-clinical heart transplantation studies have shown that ex vivo non-ischemic heart
preservation (NIHP) can be safely used for 24 h. Here we perform a prospective, open-label …

Background Donor lung use for transplantation is the lowest among solid organ tranplants
because of several complex and multifactorial reasons; one area that could have a …

Organ gene therapy represents a promising tool to correct diseases or improve graft survival
after transplantation. Polymorphic variation of the major histocompatibility complex (MHC) …

Objective: Ex vivo organ perfusion is an advanced preservation technique that allows graft
assessment and extended ex situ intervals. We hypothesized that its properties might be …

Recent advancement in organ perfusion technology has led to increase clinical
transplantation of marginal donor organs and allow for distant procurement of cardiac …

Lung transplantation is a lifesaving treatment in numerous forms of end-stage lung disease
but organ shortage remains nowadays his biggest issue. Ex vivo lung perfusion (EVLP) has …

Lung donation after circulatory death : Current Opinion in Organ Transplantation Lung donation
after circulatory death : Current Opinion in Organ Transplantation Log in or Register Subscribe …